Figure 3
Figure 3. A human IgG1 molecule. Heavy (γ) chains are clear; light (κ or λ) chains are shaded. Individual domains (V, variable; C, constant) are depicted as rectangles. The paired Cγ2 and Cγ3 domains with their N-linked glycans (yellow) make up the Fcγ module. The remainder of the molecule (including its hinge) is composed of 2 Fab′γ modules. The hinge (γ-chain residues 221-237) has a rigid core with 2 γ-γ interchain disulfide bonds, whereas the upper and lower hinges are flexible. One of the 2 set of docking sites on Fcγ is shown. The site for all Fcγ receptors (red) involves the medial aspects of both Cγ2 domains, extends into the lower hinge, and has a floor formed by the 2 Fcγ glycans.107 The site for FcRn (blue) involves both Cγ2 and Cγ3 domains at their interface.109 The site for complement C1q (green) is on the surface of the Cγ2 domain lateral to the Fcγ receptor site.110 The contralateral set of sites is obscured. In the FabIgG derivative,108 the hinge disulfide bonds are cleaved; and a third Fab′γ module, with antibody specificity for the activating FcγRIIIA, is attached to one of the resulting cysteine residues. The original FcγR site is deliberately disabled so that there is little residual affinity for FcγRIIB. The sites for FcRn and complement C1q are little affected.

A human IgG1 molecule. Heavy (γ) chains are clear; light (κ or λ) chains are shaded. Individual domains (V, variable; C, constant) are depicted as rectangles. The paired Cγ2 and Cγ3 domains with their N-linked glycans (yellow) make up the Fcγ module. The remainder of the molecule (including its hinge) is composed of 2 Fab′γ modules. The hinge (γ-chain residues 221-237) has a rigid core with 2 γ-γ interchain disulfide bonds, whereas the upper and lower hinges are flexible. One of the 2 set of docking sites on Fcγ is shown. The site for all Fcγ receptors (red) involves the medial aspects of both Cγ2 domains, extends into the lower hinge, and has a floor formed by the 2 Fcγ glycans.107  The site for FcRn (blue) involves both Cγ2 and Cγ3 domains at their interface.109  The site for complement C1q (green) is on the surface of the Cγ2 domain lateral to the Fcγ receptor site.110  The contralateral set of sites is obscured. In the FabIgG derivative,108  the hinge disulfide bonds are cleaved; and a third Fab′γ module, with antibody specificity for the activating FcγRIIIA, is attached to one of the resulting cysteine residues. The original FcγR site is deliberately disabled so that there is little residual affinity for FcγRIIB. The sites for FcRn and complement C1q are little affected.

Close Modal

or Create an Account

Close Modal
Close Modal